Vivos Therapeutics Inc

NASDAQ:VVOSUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization of a suit of diagnostic and multi-disciplinary treatment modalities for patients with cranial and/or dentofacial abnormalities and an array of medical conditions, including mild to moderate obstructive sleep apnea (OSA) and snoring in adults. The Company's Vivos Method is a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities and/or mild to moderate OSA and snoring. The Company's program is to train dentists and offer them other value-added services in connection with their ordering and use of the Vivos System for patients is called the Vivos Integrated Practice program. The Vivos Method comprises of various products and services, such as Vivos Complete Airway Repositioning and/or Expansion (CARE) oral appliance therapy; VivosGuides; Vivos Versa; POD and Night Block, and VivosMyoCorrect.

Contact Information

Headquarters

7921 Southpark Plaza,, Suite 210LITTLETON, CO, United States 80120

Phone

---

Fax

302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder

R. Kirk Huntsman

Chief Financial Officer

Bradford Amman

Independent Director

Ralph Green

Independent Director

Anja Krammer

Independent Director

Mark Lindsay